Tag Archive | "head and neck cancer"

Expert says Nivolumab Poised to Change Standard of Care in SCCHN

Wednesday, August 24, 2016

0 Comments

Source: www.onclive.com Author: Laura Panjwani Nivolumab (Opdivo) is a game-changing agent for the treatment of patients with squamous cell carcinoma of the head and neck (SCCHN), according to Robert L. Ferris, MD, PhD. “Recent findings have shown us that this agent is really the new standard-of-care option for all platinum-refractory patients with head and neck […]

Continue reading...

FDA Spends $36 Million on Anti-Chewing Tobacco Ad Campaign

Thursday, April 21, 2016

0 Comments

Source: www.freebeacon.com Author: Elizabeth Harrington The Food and Drug Administration is spending $36 million on an anti-chewing tobacco advertising campaign targeted at white male teenagers in the midwest. The federal agency announced Tuesday it is expanding its “Real Cost” anti-tobacco campaign to “educate rural, white male teenagers” and convince them to stop dipping. “Smokeless tobacco […]

Continue reading...

Minimizing Imaging for Recurrence of HPV-Associated Head & Neck Cancer

Monday, April 18, 2016

0 Comments

Source: www.journals.lww.com/oncologytimes Author: Robert H. Carlson   SCOTTSDALE, ARIZ.—Most recurrences of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) can be found through imaging and physical exams within six months after treatment, according to a study from the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Fla. “For most patients with HPV-associated oropharyngeal cancer who […]

Continue reading...

Head & Neck Cancer Patients Face Social Isolation, Financial Burdens

Monday, April 18, 2016

0 Comments

Source: www.journals.lww.com/oncologytimes Author: Robert H. Carlson   SCOTTSDALE, Ariz.—Locally advanced head and neck cancer (LAHNC) has high morbidity and is expensive to treat. The cost of the disease, not only in financial burden but also degradation of the patient’s quality of life, was highlighted in a recent study from University of Chicago Pritzker School of […]

Continue reading...

ASCO Urges Aggressive Efforts to Increase HPV Vaccination

Monday, April 18, 2016

0 Comments

Source: www.medscape.com Author: Zosia Chustecka   Human papillomavirus (HPV) vaccines have now been available for 10 years, but despite many medical professional bodies strongly recommending the vaccine, uptake in the United States remains low. Data from a national survey show that about 36% of girls and 14% of boys have received the full schedule of […]

Continue reading...

Merck Says FDA Accepts Its SBLA For Keytruda For Treatment Of Head & Neck Cancer

Wednesday, April 13, 2016

0 Comments

Source: www.finchannel.com Author: Fin Channel News Editorial Staff   The FINANCIAL — Merck, known as MSD outside the United States and Canada, on April 13 announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of […]

Continue reading...

Suicide: A Major Threat to Head and Neck Cancer Survivorship

Thursday, March 24, 2016

0 Comments

Source: www.jco.ascopubs.com Authors: Nosayaba Osazuwa-Peters, Eric Adjei Boakye, and Ronald J. Walker
, Mark A. Varvares   TO THE EDITOR: The article by Ringash that was recently published in Journal of Clinical Oncology provided a compelling narrative of both the improvements made in head and neck cancer survivorship, as well as the challenges created by longer-term […]

Continue reading...

The Oral Cancer Foundation’s Founder, Brian R. Hill, honored by the Global Oral Cancer Forum – International oral cancer community honor his accomplishments in the field.

Friday, March 11, 2016

0 Comments

Source: www.prnewswire.com Author: The Oral Cancer Foundation   NEWPORT BEACH, Calif., March 10, 2016 /PRNewswire-USNewswire/ — At the recent Global Oral Cancer Forum (GOCF), Brian R. Hill, Executive Director and Founder of the Oral Cancer Foundation (OCF), was honored for his work as an advocate and innovative thinker in the oral cancer arena. The GOCF organizers […]

Continue reading...

Immunotherapy Continues to Advance in Head and Neck Cancer

Monday, February 29, 2016

0 Comments

Source: www.onclive.com Author: Megan Garlapow, PhD   Concomitant administration of motolimod with cetuximab (Erbitux) increases the innate and adaptive immune response in the blood and the tumor microenvironment in head and neck squamous cell carcinoma (HNSCC), overcoming negative prognostic biomarkers of cetuximab therapy alone, according to the biomarker data from a recent phase Ib clinical […]

Continue reading...

Study: HPV vaccine reduces HPV incidence in teenage girls

Monday, February 22, 2016

0 Comments

Source: www.upi.com Author: Stephen Feller   Just over half of girls have received the HPV vaccination, but a new CDC study shows it has significantly reduced prevalence of the cancer-causing STI among females who have received the vaccine when compared with those who have not. Photo by Adam Gregor/Shutterstock   WASHINGTON, Feb. 22 (UPI) — […]

Continue reading...